Antitumor efficacy of PARP inhibitors in homologous recombination deficient carcinomas-Reference-Cited by-同舟云学术

Antitumor efficacy of PARP inhibitors in homologous recombination deficient carcinomas

Published:2019-02-23 Issue:5 Volume:145 Page:1209-1220
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Yi Tianjin¹^ORCID,Feng Yi²,Sundaram Ravi³,Tie Yan⁴,Zheng Heng¹,Qian Yanping¹,You Di¹,Yi Tao¹,Wang Ping¹,Zhao Xia¹

Affiliation:

1. Department of Gynecology and Obstetrics, Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of EducationWest China Second University Hospital, Sichuan University Chengdu Sichuan, People's Republic of China

2. Ovarian Cancer Research CenterUniversity of Pennsylvania, Perelman School of Medicine Philadelphia PA

3. Center for Cancer Research at Massachusetts General HospitalHarvard Medical School Boston MA

4. State Key Laboratory of Biotherapy and Cancer CenterWest China Hospital, Sichuan University Chengdu Sichuan People's Republic of China

Funder

China Scholarship Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32143

Reference25 articles.